A treatment for post-COVID is being studied at the HUG
You can take part in this clinical trial at Geneva University Hospitals
2022
The SEROCoV-Schools study wins the Prix Médecine et Société
Recognition of the societal impact of this project carried out in schools during the pandemic
Stories from Covid long: a collective work
A sound sculpture created by people living with post-COVID syndrome and artists will be inaugurated at the HUG on 4 October.
Results of the fourth stage of the seroprevalence study are imminent
The study was able to count on the renewed commitment of 2,521 people between 29 April and 9 June.
Over 93% of the population of Geneva has developed antibodies against SARS-CoV-2
Our latest seroprevalence study also shows that only half of these people have antibodies that neutralise Omicron variants.